Contents IGIV Supply and Distribution - Key Findings IGIV Demand - Key Fundings IGIV Access Problems- Key Fundings Immune globulin intravenous (IGIV), also referred to as intravenous immune globulin (IVIG), is a valuable treatment for many seriously ill patients. Although the U.S.
Office of Science and Data Policy (SDP)
The Office of Science and Data Policy is the departmental focal point for policy research, analysis, evaluation, and coordination of department-wide public health science policy and data policy activities and issues. The Office provides authoritative advice and analytical support to the ASPE and departmental leadership on public health science policy and data policy issues and initiatives, coordinates science and data policy issues of interagency scope within HHS, and manages interagency initiatives in science policy and data policy. The Office works closely with staff from across the Department on strategic plan development and implementation efforts. The Offices also carries out a program of policy research, analysis, evaluation, and data development in these issues.
The Office of Science and Data Policy includes several components:
- Division of Science and Public Health Policy
- Division of Evidence, Evaluation and Data Policy
- Division of Strategic Planning
Topic Areas:
- HHS Data Council
- Regulatory Impact Analysis
- Strategic Planning
- Information Quality Guidelines
- Prevention and wellness
- Public health systems and functions
- Food safety and nutrition
- Drugs and devices
- Tobacco control and prevention
- Biomedical research and development
- Economic analysis
- Emergency preparedness, response, and recovery
- Data and statistical policy
- Health disparities and vulnerable populations
- Health information technology
- Microsimulation
- Privacy policy
Reports
Displaying 161 - 170 of 183. 10 per page. Page 17.
Advanced SearchCost Effectiveness Considerations in the Approval and Adoption of New Health Technologies
Contents Background and Purpose Methodology Summary of Key Findings and Stakeholder Suggestions Conclusions and Policy Implications A.
Assessing the Economics of EMR Adoption and Successful Implementation in Physician Small Practice Settings
By: Moshman Associates, Booz, Allen, Hamilton This report is currently only available in PDF format.
Understanding Variations in International Drug Prices
Rapidly rising prescription drug prices have caused many consumers, third-party payers, and policymakers to look for ways to lower their drug costs. One strategy that many have seen as a potential solution is to import drug products from countries where drug prices are lower than those in the United States commonly called reimportation.
Community Health Center Information Systems Assessment: Issues and Opportunities
The Office of the Assistant Secretary for Planning and Evaluation (ASPE), in close collaboration with the Health Resources and Services Administration (HRSA), contracted with NORC to conduct an assessment of information technology use in ambulatory care health centers whose funding is administered by HRSA's Bureau of Primary Healthcare (BPHC).
Community Health Center Information Systems Assessment: Issues and Opportunities. Final Report
Prepared by: NORC at the University of Chicago Dan Gaylin, M.P.A. Sidra Goldman Alana Ketchel Adil Moiduddin, M.P.P. October 2005 This report is available on the Internet at:http://aspe.hhs.gov/sp/chc